October 12, 2020October 19, 2020Part 2 Tetanus: DTaP – 5 times by 5 years Risks/Benefit Analysis by Kathryn0 comments
October 11, 2020October 19, 2020Part 3 Pertussis: DTaP – 5 times by 5 years Risks/Benefit Analysis by Kathryn0 comments
October 10, 2020October 24, 2020Haemophilus Influenzae (HIB) Risks/Benefit Analysis by Kathryn0 comments
October 9, 2020October 14, 2020Pneumococcal conjugate (PCV13) Risks/Benefit Analysis by Kathryn0 comments
